Javascript must be enabled to continue!
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI
View through CrossRef
Abstract
Background
Perioperative acute kidney injury (AKI) caused by ischemia–reperfusion (IR) is a significant contributor to mortality and morbidity after major surgery. Furosemide is commonly used in postoperative patients to promote diuresis and reduce tissue edema. However, the effects of furosemide on renal microcirculation, oxygenation and function are poorly understood during perioperative period following ischemic insult. Herein, we investigated the effects of furosemide in rats subjected IR insult.
Methods
24 Wistar albino rats were divided into 4 groups, with 6 in each; Sham-operated Control (C), Control + Furosemide (C + F), ischemia/reperfusion (IR), and IR + F. After induction of anesthesia (BL), supra-aortic occlusion was applied to IR and IR + F groups for 45 min followed by ongoing reperfusion for 15 min (T1) and 2 h (T2). Furosemide infusion was initiated simultaneously in the intervention groups after ischemia. Renal blood flow (RBF), vascular resistance (RVR), oxygen delivery (DO
2ren
) and consumption (VO
2ren
), sodium reabsorption (TNa
+
), oxygen utilization efficiency (VO
2
/TNa
+
), cortical (CμO
2
) and medullary (MμO
2
) microvascular oxygen pressures, urine output (UO) and creatinine clearance (Ccr) were measured. Biomarkers of inflammation, oxidative and nitrosative stress were measured and kidneys were harvested for histological analysis.
Results
IR significantly decreased RBF, mainly by increasing RVR, which was exacerbated in the IR + F group at T2 (2198 ± 879 vs 4233 ± 2636 dyne/s/cm
5
, p = 0.07). CμO
2
(61.6 ± 6.8 vs 86 ± 6.6 mmHg) and MμO
2
(51.1 ± 4.1 vs 68.7 ± 4.9 mmHg, p < 0.05) were both reduced after IR and did not improve by furosemide. Moreover, VO
2
/TNa
+
increased in the IR + F group at T2 with respect to the IR group (IR: 3.3 ± 2 vs IR + F: 8.2 ± 10 p = 0.07) suggesting a possible deterioration of oxygen utilization. Ccr did not change, but plasma creatinine increased significantly in IR + F groups. Histopathology revealed widespread damage both in the cortex and medulla in IR, IR + F and C + F groups.
Conclusion
Renal microvascular oxygenation, renal function, renal vascular resistance, oxygen utilization and damage were not improved by furosemide administration after IR insult. Our study suggests that furosemide may cause additional structural and functional impairment to the kidney following ischemic injury and should be used with caution.
Springer Science and Business Media LLC
Title: Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI
Description:
Abstract
Background
Perioperative acute kidney injury (AKI) caused by ischemia–reperfusion (IR) is a significant contributor to mortality and morbidity after major surgery.
Furosemide is commonly used in postoperative patients to promote diuresis and reduce tissue edema.
However, the effects of furosemide on renal microcirculation, oxygenation and function are poorly understood during perioperative period following ischemic insult.
Herein, we investigated the effects of furosemide in rats subjected IR insult.
Methods
24 Wistar albino rats were divided into 4 groups, with 6 in each; Sham-operated Control (C), Control + Furosemide (C + F), ischemia/reperfusion (IR), and IR + F.
After induction of anesthesia (BL), supra-aortic occlusion was applied to IR and IR + F groups for 45 min followed by ongoing reperfusion for 15 min (T1) and 2 h (T2).
Furosemide infusion was initiated simultaneously in the intervention groups after ischemia.
Renal blood flow (RBF), vascular resistance (RVR), oxygen delivery (DO
2ren
) and consumption (VO
2ren
), sodium reabsorption (TNa
+
), oxygen utilization efficiency (VO
2
/TNa
+
), cortical (CμO
2
) and medullary (MμO
2
) microvascular oxygen pressures, urine output (UO) and creatinine clearance (Ccr) were measured.
Biomarkers of inflammation, oxidative and nitrosative stress were measured and kidneys were harvested for histological analysis.
Results
IR significantly decreased RBF, mainly by increasing RVR, which was exacerbated in the IR + F group at T2 (2198 ± 879 vs 4233 ± 2636 dyne/s/cm
5
, p = 0.
07).
CμO
2
(61.
6 ± 6.
8 vs 86 ± 6.
6 mmHg) and MμO
2
(51.
1 ± 4.
1 vs 68.
7 ± 4.
9 mmHg, p < 0.
05) were both reduced after IR and did not improve by furosemide.
Moreover, VO
2
/TNa
+
increased in the IR + F group at T2 with respect to the IR group (IR: 3.
3 ± 2 vs IR + F: 8.
2 ± 10 p = 0.
07) suggesting a possible deterioration of oxygen utilization.
Ccr did not change, but plasma creatinine increased significantly in IR + F groups.
Histopathology revealed widespread damage both in the cortex and medulla in IR, IR + F and C + F groups.
Conclusion
Renal microvascular oxygenation, renal function, renal vascular resistance, oxygen utilization and damage were not improved by furosemide administration after IR insult.
Our study suggests that furosemide may cause additional structural and functional impairment to the kidney following ischemic injury and should be used with caution.
Related Results
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Objective
To observe time dependent effects of simulated ischemia-reperfusion on transient sodium currents (INa) in rat left ventricular myocytes, and effects of ...
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI.
Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AKI.
Abstract
Background: Perioperative Acute Kidney Injury (AKI) caused by Ischemia-Reperfusion (IR) is a significant contributor to mortality and morbidity after major surgery...
MO331: Acute Kidney Failure as a Risk Factor for Longer Hospital Stay, Renal Replacement Therapy and Mortality: A Public Health System Analysis
MO331: Acute Kidney Failure as a Risk Factor for Longer Hospital Stay, Renal Replacement Therapy and Mortality: A Public Health System Analysis
Abstract
BACKGROUND AND AIMS
Acute kidney failure (AKI) is a well-known risk factor in coronary care unit (CCU) and postoperativ...
Renoprotective effects Of Dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
Renoprotective effects Of Dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
Abstract
Background
Diabetic patients are susceptible to renal ischemia-reperfusion injury, which leads to perioperative compli...
Acute Kidney Injury in Pregnancy and HELLP Syndrome
Acute Kidney Injury in Pregnancy and HELLP Syndrome
INTRODUCTION
Acute kidney injury (AKI) during pregnancy is associated with rates of maternal mortality and fetal loss that range from 30–60%. Given that preecla...
Furosemide in the management of acute kidney injury in the pediatric intensive care unit—retrospective cohort study
Furosemide in the management of acute kidney injury in the pediatric intensive care unit—retrospective cohort study
Abstract
Objective
To evaluate the effects of furosemide administration in critically ill children on the progression of acute kidney injury (AKI) a...
The combination of Pitavastain and ischemic postconditioning attenuates myocardial ischemic/reperfusion injury in impaired glucose tolerance rat in vivo
The combination of Pitavastain and ischemic postconditioning attenuates myocardial ischemic/reperfusion injury in impaired glucose tolerance rat in vivo
Background and Objectives
Myocardial ischemia-reperfusion injury (MIRI) can be alleviated by ischemia post-conditioning (IPC) and/or statin post-conditioning (SPC...
Factors associated with acute kidney injury among patients with cancer treated with immune checkpoint inhibitor therapy: A population-based study.
Factors associated with acute kidney injury among patients with cancer treated with immune checkpoint inhibitor therapy: A population-based study.
2584 Background: Cancer immune checkpoint inhibitor (ICI) therapy may be associated with kidney immune-related adverse events (IRAEs) and other causes of acute kidney injury (AKI)...

